Immunopharmacology and Immunotoxicology 2015-04-01

The effect of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on lymphocyte subsets and humoral immune response in SRBC-immunized mice.

Angelika Drynda, Bożena Obmińska-Mrukowicz, Marcin Mączyński, Stanisław Ryng

Index: Immunopharmacol. Immunotoxicol. 37(2) , 148-57, (2015)

Full Text: HTML

Abstract

5-Amino-3-methyl-4-isoxazolecarboxylic acid hydrazide is a non-cytotoxic synthetic isoxazole derivative with considerable immunomodulatory properties demonstrated in in vitro experiments. The aim of this study was to investigate the influence of this compound, depending on the dosage and schedule of treatment, on lymphocyte subsets in non-immunized mice and humoral immune response in SRBC (sheep red blood cells)-immunized mice. An analysis of lymphocyte subsets was carried out by flow cytometry, using specific monoclonal antibodies stained with fluorescein isothiocyanate (FITC) or phycoerythrin (PE). In the SRBC-immunized mice, the influence of the compound on the humoral response was determined, depending on the time of administration relative to the antigen. The number of plaque forming cells (PFC) was determined by a local hemolysis technique in an agar gel. Total and 2-mercaptoethanol resistant serum agglutination titers were defined by active hemagglutination test carried out on microplates. The investigated hydrazide was able to modulate the percentage and absolute number of T lymphocyte subsets in the thymus, and T and B lymphocytes in the peripheral lymphatic organs. It also enhanced humoral immune response in SRBC-immunized mice by increasing the number of cells producing hemolytic anti-SRBC antibodies (PFC) and by augmenting the level of total and 2-mercaptoethanol resistant hemagglutinin. The present study showed modulatory effects of 5-amino-3-methyl-4-isoxazolecarboxylic acid hydrazide on lymphocyte subsets and humoral immune response in mice. This compound could be potentially useful for the treatment of autoimmune diseases, infections or as an adjuvant for boosting the efficacy of vaccines.


Related Compounds

Related Articles:

Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited.

2015-03-01

[Stroke 46(3) , 835-42, (2015)]

Suppression of the HSF1-mediated proteotoxic stress response by the metabolic stress sensor AMPK.

2015-02-03

[EMBO J. 34(3) , 275-93, (2015)]

Detailed characterization of a long-term rodent model of critical illness and recovery.

2015-03-01

[Crit. Care Med. 43(3) , e84-96, (2015)]

The chemokine (CCL2-CCR2) signaling axis mediates perineural invasion.

2015-02-01

[Mol. Cancer Res. 13(2) , 380-90, (2015)]

Developmental tightening of cerebellar cortical synaptic influx-release coupling.

2015-02-04

[J. Neurosci. 35(5) , 1858-71, (2015)]

More Articles...